Microbiome firm BiomX is to continue collaborating with pharma giants Boehringer Ingelheim in a partnership that looks to identify biomarkers for inflammatory bowel disease (IBD).
Given that most of the Summer months were in lockdown, August and September were surprisingly busy months for acquisitions and collaborations. Here, NutraIngredients rounds up the best of them.
The UK branch of German pharma player Boehringer Ingelheim has had brain health adverts for a vitamin-based medicine backed by local watchdog, the Advertising Standards Authority (ASA).
German company Boehringer Ingelheim received a US patent yesterday
for its extract of red vine leaves which can be used as a treatment
for chronic venous insufficiency.
German pharmaceutical and ingredients group Boehringer Ingelheim
reported a healthy rise in profits for 2002 this week, with
directors describing its current status as "extremely sound and
robust".
Canada's PanGeo Pharma group has acquired the Quest Consumer Health
Care business of Boehringer Ingelheim (Canada) for approximately
C$14 million (€10m).
The German pharmaceuticals group reports that sales in the first
six months of 2002 rose 21 per cent on the previous year to €3.7
billion while operating income showed growth of 48 per cent to €495
million. Business in the US was...
